Recent Updates
Recently added Catalysts
MYO Positive Sentiment

Myomo to Report Third Quarter Financial Results on November 6, 2024

Wednesday, October 30, 2024 BiopharmaWatch Research 1 min read
Add on Google
Key Takeaway: Myomo, Inc. has announced it will report its financial results for the third quarter ending September 30, 2024, on November 6, 2024. The company specializes in wearable medical robotics aimed at aiding individuals with neurological disorders and upper-limb paralysis. This report reflects Myomo's commitment to transparency and progress.
Price reaction · baseline $3.85 (2024-10-30T15:52:00.000Z) · hit during market hours · clean, no other MYO news in the window
day 0 close · peak
+1.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Myomo is actively reporting its financial results.
  • The company is focused on improving functionality for patients.
  • The upcoming report indicates growth and transparency.

Full Press Release Details

BOSTON (October 30, 2024) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that it will report financial results for the third quarter ended September 30, 2024 on November 6, 2024. Read more .

Frequently Asked Questions

When will Myomo report its Q3 financial results?

Myomo will report its Q3 financial results on November 6, 2024.

What is Myomo's focus area?

Myomo focuses on wearable medical robotics for neurological disorders and upper-limb paralysis.

What period do the Q3 results cover?

The Q3 results cover the period ending September 30, 2024.

Where is Myomo located?

Myomo is based in Boston.

ShareAdd on Google
Tags: MYO Viatris Investor Conferences Healthcare Myomo financial results wearable robotics neurological disorders
Last updated: Oct 30, 2024

Biotech snapshot

Cash runway
$13M liquidity · $1M/mo burn
~20 mo
Low dilution risk